GL1X · GenesisL1 explorer

UniProt P49761

Dual specificity protein kinase CLK3 (P49761)

Dual specificity protein kinase CLK3 (UniProt P49761), EC 2.7.12.1: 28 experimental structures and 1 predicted model on GenesisL1, 18 ligands bound, 2 pockets. Binding sites, druggability and experiment against prediction…

UniProt
P49761
Protein
Dual specificity protein kinase CLK3
EC
2.7.12.1
Experimental structures
28
Predicted models
1
Ligands
18
Pockets
2 · 1 record with a druggable one

Structures

29 records of P49761 in the MolNFT archive: 28 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
2EU9Crystal Structure of CLK3x-ray diffractionA——
2EU9Crystal structure of CLK3x-ray diffractionA——
2EXECrystal structure of the phosphorylated CLK3x-ray diffractionA——
2EXECrystal structure of the phosphorylated CLK3x-ray diffractionA——
2WU6Crystal Structure of the Human CLK3 in complex with DKIx-ray diffractionA——
2WU6Crystal structure of the human CLK3 in complex with dkix-ray diffractionA——
2WU7Crystal Structure of the Human CLK3 in complex with V25x-ray diffractionA——
2WU7Crystal structure of the human CLK3 in complex with V25x-ray diffractionA——
3RAWCrystal Structure of human CDC-like kinase 3 isoform in complex with leucettine L41x-ray diffractionA, B——
3RAWCrystal structure of human cdc-like kinase 3 isoform in complex with leucettine L41x-ray diffractionA, B——
6FT7Crystal structure of CLK3 in complex with compound 8Ax-ray diffractionA, BIOD, E6Q—
6FYPX-ray structure of CLK3-KD(GP-[275-632], non-PHOS.)/CX-4945 at 2.29Ax-ray diffractionA3NG—
6FYRX-ray structure of CLK3-KD(GP-[275-632], non-PHOS.)/CPD-2 at 1.42Ax-ray diffractionAEAQ—
6KHFCrystal structure of CLK3 in complex with CX-4945x-ray diffractionA3NG—
6KHFCrystal structure of CLK3 in complex with cx-4945x-ray diffractionA3NG—
6RCTCrystal structure of CLK3 in complex with T3-clkx-ray diffractionA, BJWN—
6YTWCLK3 bound with benzothiazole Tg003 (Cpd 2)x-ray diffractionA, BCL, PO4, EAE—
6YTWCLK3 bound with benzothiazole TG003 (cpd 2)x-ray diffractionA, BCL, PO4, EAE—
6YTYCLK3 A319V mutant bound with benzothiazole TG003 (cpd 2)x-ray diffractionAEAE—
6YU1CLK3 bound with beta-carboline KH-CARB13 (Cpd 3)x-ray diffractiona, cPO4, KHC—
6YU1CLK3 bound with beta-carboline kh-CARB13 (cpd 3)x-ray diffractiona, cPO4, KHC—
6Z2VCLK3 A319V mutant bound with beta-carboline kh-CARB13 (cpd 3)x-ray diffractionAKHC, K—
6Z51Crystal structure of CLK3 in complex with macrocycle ODS2002941x-ray diffractionAPO4, Q8B—
6Z52Crystal structure of CLK3 in complex with macrocycle ODS2003136x-ray diffractionA, BCL, IOD, Q8T—
6Z53Crystal structure of CLK3 in complex with macrocycle ODS2003128x-ray diffractionAPO4, Q7Z—
6Z54Crystal structure of CLK3 in complex with macrocycle ODS2003178x-ray diffractionAPO4, Q7H—
6Z55Crystal structure of CLK3 in complex with macrocycle ODS2004070x-ray diffractionA, BPO4, NA, PQ5—
9EZ3Crystal structure of human CLK3 bound to RN129x-ray diffractionASO4, A1H742 (best 0.71)
P49761AlphaFold monomer V2.0 prediction for dual specificity protein kinase CLK3 (P49761)predictedA——

Ligands

  • PO4 · Phosphate ion · in 8 records
  • 3NG · 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid · in 3 records
  • CL · Chloride ion · in 3 records
  • EAE · (1~{Z})-1-(3-ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)propan-2-one · in 3 records
  • KHC · (4~{S})-7,8-bis(chloranyl)-9-methyl-1-oxidanylidene-spiro[2,4-dihydropyrido[3,4-b]indole-3,4'-piperidine]-4-carbonitrile · in 3 records
  • IOD · Iodide ion · in 2 records
  • A1H74 · 1-(5-~{tert}-butyl-2-quinolin-6-yl-pyrazol-3-yl)-3-[3-(4-morpholin-4-yl-7~{H}-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]urea · in 1 record
  • E6Q · 3-phenyl-1~{H}-pyrrolo[3,4-g]indol-8-one · in 1 record
  • EAQ · 6-~{tert}-butyl-~{N}-[6-(1~{H}-pyrazol-4-yl)-1~{H}-imidazo[1,2-a]pyridin-2-yl]pyridine-3-carboxamide · in 1 record
  • JWN · 4-[2-methyl-1-(4-methylpiperazin-1-yl)-1-oxidanylidene-propan-2-yl]-~{N}-(6-pyridin-4-ylimidazo[1,2-a]pyridin-2-yl)benzamide · in 1 record
  • K · Potassium ion · in 1 record
  • NA · Sodium ion · in 1 record
  • PQ5 · 7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.12, 6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxylic acid · in 1 record
  • Q7H · 11,15-dimethyl-6-(oxan-4-yloxy)-8-oxa-2,11,15,19,21,23-hexazatetracyclo[15.6.1.13,7.020,24]pentacosa-1(23), 3(25),4,6,17,20(24),21-heptaen-10-one · in 1 record
  • Q7Z · 6-(2-methoxyethoxy)-11,15-dimethyl-8-oxa-2,11,15,19,21, 23-hexazatetracyclo[15.6.1.13,7.020,24]pentacosa-1(23),3(25),4,6,17,20(24),21-heptaen-10-one · in 1 record
  • Q8B · N-cyclopentyl-2-[(11,15-dimethyl-10-oxo-8-oxa-2,11,15, 19,21,23-hexazatetracyclo[15.6.1.13,7.020, 24]pentacosa-1(23),3(25),4,6,17,20(24),21-heptaen-6-yl)oxy]acetamide · in 1 record
  • Q8T · 11,15-dimethyl-6-(4-methylpiperazin-1-yl)-8-oxa-2,11, 15,19,21,23-hexazatetracyclo[15.6.1.13,7.020, 24]pentacosa-1(23),3(25),4,6,17,20(24),21-heptaen-10-one · in 1 record
  • SO4 · Sulfate ion · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.